Zumbro Discovery
Rochester · Founded 2013
About Zumbro Discovery
Zumbro Discovery, Inc. is developing a novel natriuretic peptide, MANP, for the treatment of resistant hypertension for which there is an unmet medical need for a syndrome which increases risk for heart failure, myocardial infarction, stroke and kidney disease. MANP was discovered at the Mayo Clinic and is soon entering first in human studies.
Company Facts
- Founded: 2013
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2013)
- Website: http://zumbrodiscovery.com/
Industries & Categories
Biotechnology, Clinical Trials
Canonical: https://fsome.com/organization/zumbro-discovery-2411033 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.